A Systematic Review of Duloxetine for Osteoarthritic Pain: What is the Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed?

Evidence-based medicine: it’s not just about the evidence

(2011) L. Citrome   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Pain Mechanisms in Osteoarthritis: Understanding the Role of Central Pain and Current Approaches to Its Treatment

(2011) P. J. MEASE et al.   JOURNAL OF RHEUMATOLOGY

American Academy of Orthopaedic Surgeons Clinical Practice Guideline on The Treatment of Osteoarthritis (OA) of the Knee

(2010) John Richmond et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

A Double-blind, Randomized, Placebo-controlled Study of the Efficacy and Safety of Duloxetine for the Treatment of Chronic Pain Due to Osteoarthritis of the Knee

(2010) Amy S. Chappell et al.   Pain Practice

Relative vs. absolute measures of benefit and risk: what’s the difference?

(2009) L. Citrome   ACTA PSYCHIATRICA SCANDINAVICA

Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial

(2009) Amy S. Chappell et al.   PAIN

Duloxetine for the Treatment of Recurrent Major Depressive Disorder in Elderly Patients: Treatment Outcomes in Patients With Comorbid Arthritis

(2009) Madelaine M. Wohlreich et al.   PSYCHOSOMATICS

Compelling or irrelevant? Using number needed to treat can help decide

(2008) L. Citrome   ACTA PSYCHIATRICA SCANDINAVICA

Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks

(2008) Leslie Citrome et al.   Expert Review of Neurotherapeutics